Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 12 , ISSUE 5 ( September-October, 2020 ) > List of Articles


Assessing Disease Outcome in COVID-19 Pregnancies in a Tertiary Referral Center in South India: A Single-center Retrospective Cohort Study

S Ajith, VP Reshmi

Citation Information : Ajith S, Reshmi V. Assessing Disease Outcome in COVID-19 Pregnancies in a Tertiary Referral Center in South India: A Single-center Retrospective Cohort Study. J South Asian Feder Obs Gynae 2020; 12 (5):335-339.

DOI: 10.5005/jp-journals-10006-1822

License: CC BY-NC 4.0

Published Online: 23-03-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: To study the outcome in COVID-19-positive pregnancies. Materials and methods: Data collected and analyzed retrospectively from COVID-19-positive pregnant women admitted to our hospital between April and September 2020. Results: 78.85% of women below 30 years of age, 60.57% multigravidae, 53.71% above 37 weeks of gestation. 76.85% no comorbidities, 73.42% no history of travel/contact with COVID-19 cases. 84.57% asymptomatic, two had a severe acute respiratory infection (SARI), requiring intensive care. 74.57% diagnosed using reverse transcriptase-polymerase chain reaction (RT-PCR). 91.42% turned negative within 6–10 days. The SARI patients required intensive care unit (ICU) care, one expired. 81.42% discharged between 8 days and 14 days of admission, returned for delivery at term. 83.42% required no medication. 96.28% had normal investigation reports. 83.14% of patients discharged, 16.57% required emergency obstetric intervention. Cesarean section rate 52.28%, the previous cesarean section most common indication (43.16%). Two babies were stillborn. 99.20%, Apgar > 7 at 5 minutes. Two required resuscitations. Nine required neonatal intensive care unit (NICU) admission. Two hundred and seven babies isolated from their mother, four turned positive. Forty-four were roomed in with mothers, 30 turned positive. One hundred and sixty-seven were breastfed, included 34 positive babies. Affected babies were asymptomatic. Conclusion: COVID-19 runs a milder course in pregnancy, possibly due to altered immune status. However, severe cases can deteriorate rapidly. There is evidence of community spread. COVID-19 seemed to increase cesarean rates. Neonatal transmission appeared higher following vaginal deliveries, rooming-in, and breastfeeding. Clinical significance: There is a dearth of adequate data to formulate guidelines about COVID-19-positive pregnancies despite numerous studies. We hope that our findings make a humble addition to ongoing research and provide further impetus to the global fight against this pandemic.

  1. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020;395(10226):809–815. DOI: 10.1016/S0140-6736(20)30360-3.
  2. Report of the WHO China joint mission on coronavirus disease2019 (COVID-19) [Internet]. Beijing: World Health Organisation; 2020.
  3. , Coronavirus disease 2019 (COVID-19) during pregnancy: a case series. 2020.
  4. Clinical analysis of 10 neonates born to mothers with 2019-nCov pneumonia. Transl Pediatr 2020;9(1):51–60. DOI: 10.21037/tp.2020.02.06.
  5. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect 2020. DOI: 10.1016/j.jinf.2020.02.028.
  6. A case of 2019 novel coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis 2020(15):ciaa200. DOI: 10.1093/cid/ciaa200.
  7. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. Am J Roentgenol 2020;215(1):1–6. DOI: 10.2214/AJR.20.23072.
  8. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-center, descriptive study. Lancet Infect Dis 2020;20(5):559–564. DOI: 10.1016/S1473-3099(20)30176-6.
  9. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 2020;26(6):1335–1336. DOI: 10.3201/eid2606.200287.
  10. Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry? Clin Infect Dis 2020. ciaa226. DOI: 10.1093/cid/ciaa226.
  11. A case report of neonatal 2019 coronavirus disease in China. Clin Infect Dis 2020;71(15):853–857. DOI: 10.1093/cid/ciaa225.
  12. A pregnant woman with COVID-19 in Central America. Travel Med Infect Dis 2020. 101639. DOI: 10.1016/j.tmaid.2020.101639.
  13. An uncomplicated delivery in a patient with COVID-19 in the United States. N Engl J Med 2020;382(16):e34. DOI: 10.1056/NEJMc2007605.
  14. Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) confirmed patient. Korean J Anesthesiol 2020;73(4):347–351. DOI: 10.4097/kja.20116.
  15. Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children. J Infect 2020;80(5):e7–e13. DOI: 10.1016/j.jinf.2020.03.007.
  16. 2020 [cited 29 April 2020]. Available from:–17-coronavirus-covid-19-infection-inpregnancy.pdf.
  17. Mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological and histopathological findings. Travel Med Infect Dis 2020. 101665. DOI: 10.1016/j.tmaid.2020.101665.
  18. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020;55(5):586–592. DOI: 10.1002/uog.22014.
  19. Maternal death due to COVID-19 disease. Am J Obst Gynecol 2020;223(1):109.e1–109.e16. DOI: 10.1016/j.ajog.2020.04.030.
  20. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA 2020;323(21):2198–2200. DOI: 10.1001/jama.2020.7233.
  21. Placental pathology in COVID-19. Am J Clin Pathol 2020;154(1):23–32. DOI: 10.1093/ajcp/aqaa089.
  22. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA 2020;323(18):1848–1849. DOI: 10.1001/jama.2020.4861.
  23. Possible vertical transmission of SARSCoV-2 from an infected mother to her newborn. JAMA. 2020 323(18):1846–1848.
  24. Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr 2020;8:104. DOI: 10.3389/fped.2020.00104.
  25. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clin Infect Dis 2020;71(16):2035–2041. DOI: 10.1093/cid/ciaa352.
  26. Detection of SARS-COV-2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM 2020(3):100133. DOI: 10.1016/j.ajogmf.2020.100133.
  27. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017;17(8):469–482. DOI: 10.1038/nri.2017.64.
  28. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARSCoV-2 infection: an international cohort study. Lancet 2020;396(10243):27–38. DOI: 10.1016/S0140-6736(20)31182-X.
  29. COVID-19 and multiorgan response. Curr Probl Cardiol 2020;45(8):100618. DOI: 10.1016/j.cpcardiol.2020.100618.
  30. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life Sci 2020;254:117788. DOI: 10.1016/j.lfs.2020.117788.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.